Podophyllum Peltatum Root

Dosage for Podophyllum Peltatum Root varies significantly based on the intended clinical purpose. Because it is a non-standardized extract, there is no universal 'milligram' dose that applies to all patients. Instead, dosing is often expressed in terms of weight/volume (w/v) or protein nitrogen units (PNU).

• Allergy Prick Testing: Typically, a concentration of 1:10 or 1:20 w/v is used. A single drop is applied to the skin, followed by a puncture or prick. The results are read after 15–20 minutes.
• Intradermal Testing: If the prick test is negative, a more sensitive intradermal test may be performed using a much more dilute solution (e.g., 1:100 or 1:1000 w/v). Usually, 0.02 mL to 0.05 mL is injected to create a small bleb.
• Immunotherapy: Dosing begins at a very low concentration (e.g., 1:100,000 w/v) and is gradually increased over several months based on the patient's tolerance and the healthcare provider's protocol.

Podophyllum Peltatum Root extracts are generally not recommended for routine use in children unless specifically indicated for allergy diagnosis by a pediatric allergist.

• Diagnostic Testing: Pediatric dosing for skin testing is similar to adult dosing in terms of concentration, but the number of tests performed at one time may be limited to prevent excessive discomfort or systemic reactions.
• Safety: The use of Podophyllum derivatives is strictly contraindicated in neonates and infants due to the risk of systemic absorption and profound toxicity.

Renal Impairment

For diagnostic skin testing, no dosage adjustment is typically required as systemic absorption is minimal. However, if systemic exposure is suspected, clinicians must be aware that renal clearance is a primary route of elimination for podophyllotoxin metabolites, and impaired kidney function could prolong toxicity.

Hepatic Impairment

Since the active lignans in the root are metabolized by the liver, patients with severe hepatic impairment (Child-Pugh Class C) should be monitored closely if undergoing extensive immunotherapy, as the metabolic clearance of the antigens may be reduced.

Elderly Patients

Elderly patients may have thinner skin, which can affect the interpretation of skin tests (increased risk of false positives or mechanical irritation). Healthcare providers should use caution and consider the patient's overall skin integrity and immune status.

Podophyllum Peltatum Root extract is almost exclusively administered by a healthcare professional in a clinical setting.

• Administration: For allergy testing, the skin (usually the forearm or back) is cleaned with alcohol. The extract is applied, and the skin is pricked. The area must remain dry and undisturbed for 20 minutes.
• Storage: Most extracts must be stored in a refrigerator between 2°C and 8°C (36°F to 46°F). They should not be frozen. Glycerinated extracts are stable but can lose potency if exposed to high temperatures for extended periods.
• Homeopathic Use: If using homeopathic pellets, they should be dissolved under the tongue without touching them with the hands, usually 30 minutes before or after eating.

In the context of allergy immunotherapy, a missed dose can disrupt the desensitization process. If a dose is missed, contact your allergist immediately. Depending on how much time has passed, the doctor may need to maintain the previous dose or even reduce the dose for the next injection to ensure safety and prevent a severe reaction.

An 'overdose' of Podophyllum Peltatum Root extract in a clinical setting usually manifests as an exaggerated local reaction or a systemic allergic reaction (anaphylaxis).

• Signs of Systemic Toxicity (Ingestion): Severe abdominal pain, violent vomiting, diarrhea, bone marrow suppression (low white blood cell count), and peripheral neuropathy (tingling or numbness in hands and feet).
• Emergency Measures: If systemic anaphylaxis occurs, epinephrine is the first-line treatment. If the raw root is ingested, immediate emergency medical attention is required. There is no specific antidote; treatment is supportive, focusing on fluid replacement and monitoring of neurological and hematological status.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to use this substance without medical guidance.

When used as a diagnostic allergenic extract, the most common side effects are localized to the site of administration. These are often expected as part of the testing process.

• Local Wheal and Flare: A raised, red, itchy bump at the test site. This typically appears within 15 minutes and resolves within a few hours.
• Pruritus (Itching): Intense itching at the site of the prick or injection.
• Erythema (Redness): Redness surrounding the test site, which may feel warm to the touch.
• Local Swelling: Minor swelling of the skin area where the extract was applied.

These side effects may occur in more sensitive individuals or those receiving immunotherapy injections:

• Delayed Local Reactions: Swelling and redness that appear 6 to 24 hours after the test or injection.
• Urticaria (Hives): Hives appearing on areas of the body other than the test site.
• Malaise: A general feeling of discomfort or fatigue following an allergy shot.
• Headache: Mild to moderate headache shortly after administration.

Rarely, patients may experience more significant reactions:

• Lymphadenopathy: Swelling of the lymph nodes near the site of administration.
• Vasovagal Response: Fainting or lightheadedness, often triggered by the needle prick rather than the extract itself.
• Persistent Granuloma: A small, firm bump at the injection site that may last for several weeks.

> Warning: Stop taking Podophyllum Peltatum Root and call your doctor immediately if you experience any of these symptoms of a systemic allergic reaction (anaphylaxis).

• Dyspnea (Shortness of Breath): Difficulty breathing, wheezing, or a feeling of chest tightness.
• Angioedema: Swelling of the face, lips, tongue, or throat, which can obstruct the airway.
• Hypotension (Low Blood Pressure): Feeling faint, dizzy, or suddenly weak; this can lead to shock.
• Rapid or Weak Pulse: A sign that the cardiovascular system is responding to a severe allergic trigger.
• Cyanosis: A bluish tint to the lips or fingernails, indicating a lack of oxygen.
• Seizures: Though extremely rare, systemic toxicity from podophyllin lignans can cause neurological excitability.

Because Podophyllum Peltatum Root contains cytotoxic lignans, chronic exposure (which is not typical for diagnostic use but may occur in industrial or improper traditional use) can lead to:

• Peripheral Neuropathy: Long-term nerve damage characterized by persistent numbness, tingling, or 'pins and needles' sensations in the extremities.
• Bone Marrow Suppression: Chronic absorption can lead to leukopenia (low white blood cells) or thrombocytopenia (low platelets), increasing the risk of infection and bleeding.
• Teratogenicity: Long-term or repeated exposure during pregnancy can cause significant fetal harm.

There is no specific FDA black box warning for the non-standardized allergenic extract of Podophyllum Peltatum Root. However, purified Podophyllin Resin (derived from the same root) carries significant warnings regarding its use. It is strictly for external use and is contraindicated in pregnancy due to its ability to cause fetal death and severe birth defects. When used as an allergenic extract, the primary 'warning' is the risk of anaphylaxis, which is common to all allergenic extracts.

Report any unusual symptoms to your healthcare provider. Even minor local reactions should be documented to help your doctor adjust future doses.

Podophyllum Peltatum Root is a biologically active substance that must be handled with extreme care. The most critical safety point is the distinction between its use as a diagnostic tool (highly controlled) and the raw plant material. The raw root is toxic and should never be ingested. Even in a clinical setting, the extract must only be administered by professionals equipped to treat severe allergic reactions, including anaphylaxis.

No FDA black box warnings for Podophyllum Peltatum Root as a non-standardized allergenic extract. However, clinicians must adhere to the general class warnings for allergenic extracts, which emphasize the risk of severe systemic reactions and the necessity of a 30-minute observation period after administration.

• Allergic Reactions / Anaphylaxis Risk: This is the most significant risk associated with Podophyllum Peltatum Root extracts. Patients with a history of severe asthma or those currently experiencing an asthma exacerbation are at a higher risk for a severe reaction. The extract should not be administered during an acute illness.
• Cytotoxicity: Because the root contains podophyllotoxin, any situation that leads to significant systemic absorption (e.g., application to large areas of broken skin) can lead to multi-organ failure. Symptoms include severe GI distress followed by neurological and hematological complications.
• Skin Sensitivity: Patients with severe eczema or dermatitis may have unreliable skin test results. Testing should be performed on clear areas of skin.
• Neurological Risks: In cases of accidental ingestion or over-absorption, Podophyllum can cause 'Podophyllin encephalopathy,' characterized by confusion, hallucinations, and coma.

• Immediate Observation: Patients must be monitored for at least 30 minutes following any skin test or immunotherapy injection to watch for signs of anaphylaxis.
• Peak Flow Monitoring: For patients with asthma, a peak flow meter may be used before and after administration to ensure airway stability.
• Long-term Monitoring: If a patient is on a long-term immunotherapy protocol, periodic review of their overall allergy symptoms and systemic health is required.

Generally, Podophyllum Peltatum Root extract does not affect the ability to drive or operate machinery. However, if a patient experiences a vasovagal reaction (fainting) or a systemic allergic reaction, they should not drive until they have fully recovered and been cleared by a medical professional.

There is no direct interaction between alcohol and the diagnostic use of Podophyllum Peltatum Root. However, alcohol consumption can sometimes exacerbate allergic symptoms or increase the rate of systemic absorption by dilating blood vessels. It is generally advised to avoid alcohol on the day of allergy testing.

There is no withdrawal syndrome associated with Podophyllum Peltatum Root. However, if immunotherapy is discontinued prematurely, the patient will lose the progress made toward desensitization, and their allergy symptoms may return to baseline levels.

> Important: Discuss all your medical conditions, especially asthma or heart disease, with your healthcare provider before starting Podophyllum Peltatum Root.

• Beta-Blockers (e.g., Propranolol, Atenolol): These medications are often contraindicated for patients receiving allergenic extracts. The reason is not a direct interaction with the root, but rather that beta-blockers can make a systemic allergic reaction (anaphylaxis) much more difficult to treat. They block the effects of epinephrine, the primary treatment for anaphylaxis.
• ACE Inhibitors (e.g., Lisinopril): Similar to beta-blockers, ACE inhibitors may increase the risk of more severe systemic reactions to allergenic extracts.

• Immunosuppressants (e.g., Cyclosporine, Prednisone): These drugs can suppress the immune response, leading to false-negative results during diagnostic skin testing. If a patient is on high-dose steroids, the healthcare provider may delay testing.
• Chemotherapeutic Agents: Since Podophyllum is the source of certain chemo drugs, concurrent use might theoretically increase the risk of cytotoxic side effects, though this is unlikely with diagnostic extract levels.

• Antihistamines (e.g., Loratadine, Cetirizine): These must be discontinued several days (usually 3–7 days) before skin testing. They block the H1 receptors, preventing the 'wheal and flare' response and making the test results invalid.
• Tricyclic Antidepressants (TCAs) (e.g., Amitriptyline): These drugs have potent antihistamine properties and can interfere with diagnostic skin tests for up to two weeks after the last dose.
• H2 Blockers (e.g., Famotidine): While less potent than H1 blockers, they can still slightly diminish the skin test response.

There are no known specific food interactions with the diagnostic extract. However, patients with a known allergy to Mayapple may also show cross-reactivity with other plants in the Berberidaceae family. Consuming foods that increase systemic histamine levels (like aged cheeses or fermented foods) may theoretically make a skin test reaction more pronounced.

• St. John's Wort: May induce enzymes that metabolize the lignans in Podophyllum, potentially reducing the duration of any systemic exposure, though this is clinically minor for extracts.
• Quercetin Supplements: Since the root naturally contains quercetin, supplemental intake may interfere with the standardization of the body's response to the extract.

• Skin Prick Tests: Podophyllum Peltatum Root is the subject of the test, but its presence can interfere with other skin tests if the reactions are so large they overlap.
• Liver Function Tests: In rare cases of systemic absorption or toxicity, elevations in AST and ALT may be observed.

For each major interaction, the management strategy usually involves a 'washout period' where the interfering medication is stopped under medical supervision before the Podophyllum extract is used for diagnosis.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for allergies, depression, or blood pressure.

• Hypersensitivity to the Extract: If a patient has previously experienced a life-threatening systemic reaction (anaphylaxis) to Podophyllum Peltatum Root or any of its components (like glycerin in the base), they must never receive the extract again.
• Pregnancy: The use of Podophyllum-derived products is absolutely contraindicated in pregnancy. The active lignans are known to be teratogenic (cause birth defects) and can cause fetal death. While the risk from a single skin test is low, the potential for harm is so high that it is avoided.
• Severe or Unstable Asthma: Patients with a Forced Expiratory Volume (FEV1) of less than 70% of predicted values are at an unacceptably high risk for fatal anaphylaxis during allergy testing or immunotherapy.

• Acute Infection or Fever: Testing should be postponed until the patient is well, as an active immune system can produce unreliable results or increase the risk of a systemic reaction.
• Severe Dermatitis: If the skin is extensively damaged or inflamed, there is no suitable site for testing, and the risk of systemic absorption through broken skin increases.
• Beta-Blocker Therapy: As mentioned, this makes treating a potential reaction difficult. A risk-benefit analysis must be performed by the physician.

Patients who are allergic to other members of the Berberidaceae family (such as Barberry or Oregon Grape) may exhibit cross-sensitivity to Podophyllum Peltatum Root. Clinicians should exercise caution when testing these individuals.

> Important: Your healthcare provider will evaluate your complete medical history, including your current respiratory status and medication list, before prescribing or administering Podophyllum Peltatum Root.

Podophyllum Peltatum Root is classified as a high-risk substance during pregnancy. In the context of purified podophyllin resin, it is often assigned Pregnancy Category X. The lignans in the root interfere with cell division (mitosis), which is a critical process for a developing fetus. Exposure during pregnancy has been linked to congenital malformations and fetal death. Even though the amount of lignan in a diagnostic allergenic extract is small, the standard of care is to avoid all testing and immunotherapy with this substance during pregnancy.

It is not known if the components of Podophyllum Peltatum Root extract pass into human breast milk. Because of the potential for cytotoxic effects, even at low levels, caution is advised. Most healthcare providers recommend delaying any non-essential allergy testing or the initiation of immunotherapy until after the patient has finished breastfeeding.

Podophyllum Peltatum Root is not approved for general use in children. While pediatric allergists may use it for diagnosis in specific cases, the safety and efficacy of immunotherapy using this non-standardized extract have not been established in children under the age of 6. Children are at a higher risk for systemic reactions and may be less able to communicate the early signs of anaphylaxis.

In elderly patients, the immune response may be diminished (immunosenescence), which can lead to false-negative skin test results. Additionally, the elderly are more likely to be taking medications like beta-blockers or ACE inhibitors, which complicate the safety profile. Skin integrity should be assessed, as fragile skin may tear during the prick test or absorb more of the extract than intended.

While not a primary concern for local skin testing, patients with end-stage renal disease (ESRD) should be monitored. If any systemic absorption occurs, the kidneys are responsible for excreting the water-soluble metabolites of the root's lignans. Reduced clearance could theoretically lead to prolonged exposure to these cytotoxic compounds.

Patients with significant liver disease (e.g., cirrhosis) may have altered protein levels and metabolic capacity. Since the liver is the primary site for the biotransformation of podophyllotoxin-like compounds, these patients should be approached with caution during any procedure that might involve systemic exposure.

> Important: Special populations require individualized medical assessment. Always inform your specialist if you are pregnant, planning to become pregnant, or are currently nursing.

Podophyllum Peltatum Root contains a complex mixture of resins, the most significant of which is podophyllotoxin. At the molecular level, podophyllotoxin is an antimitotic agent. It binds to the protein tubulin at a site distinct from where colchicine binds. This binding prevents the polymerization of tubulin into microtubules. Without functional microtubules, the cell cannot form a mitotic spindle, causing the cell cycle to halt in the metaphase of mitosis. This results in the death of rapidly dividing cells.

In its role as an allergenic extract, the mechanism is the induction of a Type I hypersensitivity reaction. The proteins in the root act as antigens that bind to IgE on mast cells, triggering the release of inflammatory mediators like histamine. This is the basis for the diagnostic skin test.

The pharmacodynamic response to a skin test is rapid. The onset of the 'wheal' (swelling) and 'flare' (redness) occurs within 5 to 10 minutes, peaking at 15 to 20 minutes. The duration of this effect is usually 2 to 4 hours. In immunotherapy, the pharmacodynamic goal is a long-term shift in the immune system from a Th2 (allergic) response to a Th1 (protective) response, increasing the production of IgG4 'blocking' antibodies.

| Parameter | Value |

|---|---|

| Bioavailability | Low (epicutaneous); High (ingestion) |

| Protein Binding | ~20-25% (for podophyllotoxin) |

| Half-life | 1 - 4 hours |

| Tmax | 0.5 - 2 hours (if absorbed systemically) |

| Metabolism | Hepatic (CYP3A4 involvement) |

| Excretion | Renal (primary), Fecal |

• Molecular Components: Podophyllotoxin (C22H22O8), α-peltatin, β-peltatin, quercetin, and various glycoproteins.
• Solubility: The active resins are soluble in alcohol and chloroform but poorly soluble in water; hence, diagnostic extracts often use a glycerin/water mixture.
• Structure: The primary active lignans have a tetracyclic structure with a lactone ring and a trimethoxyphenyl group.

Podophyllum Peltatum Root is classified as a Non-Standardized Plant Allergenic Extract. It belongs to the broader category of diagnostic biologicals. It is also categorized as a botanical source for Antineoplastic Lignans.